stress levels. An individually tailored protocol to address these concerns is indicated. Of note: one exception may be thyroid function, as research suggests hypothyroidism in cancer patients may confer a survival advantage and increase response to oncologic treatment in brain tumor patients. [1] [2] [3] The cancer diagnosis can prompt a client to invite healing into her life (regardless of the possibility of a medical "cure"). Healing requires a commitment to nourish one's self physically, emotionally, socially, and spiritually. The client's lifestyle, belief system, priorities, level of commitment, and support network can be evaluated, and coaching can be provided to assist the client in creating an environment of selfnurturing. 2. Complement the client's medical treatments. Targeted dietary, nutritional, and botanical strategies can be used to enhance the efficacy of conventional cancer treatments and reduce their undesirable immediate side effects and long-term toxicity. 3. Provide a comprehensive approach to cancer control. Implement evidence-based natural agents that may assist in the control of cancer cells via biological response modification (see the next section for a detailed exploration of this approach).
Emphasis should be placed on those natural agents for which scientific research supports usefulness and efficacy. The selected natural agents should have adequate safety data and, when available, known pharmacokinetics to suggest they are without risk of interaction with the client's medications or treatments.
Targeting Tumor Cells With Biological Response Modifiers
Rather than directly attacking the tumor via cytotoxic mechanisms, as do chemotherapy and radiation, biological response modifiers (BRMs) alter host response to the tumor and/or impede biological processes integral to tumor metabolism and progression. A diversity of natural BRMs should be selected to target multiple pathways:
• Reduce inflammation-reducing eicosanoid availability that may affect tumor progression, angiogenesis, and local immune suppression. This strategy also reduces steroidal anti-inflammatory drug requirements and their associated high morbidity. • Inhibit angiogenesis.
• Impede invasion, for example, by blocking metalloproteinase and protein kinase enzymes that promote invasion. • Promote redifferentiation (ie, the maturation of neoplastic cells toward a normal cell phenotype). • Induce apoptosis (ie, programmed cell death).
• Boost immune competence, maximizing both natural and acquired immune activity against tumor cells and reducing the risk of opportunistic infections associated with prolonged use of dexamethasone use and/ or repeated cycles of chemotherapy.
It is unlikely that focus on a solitary pathway will achieve a significant clinical benefit. A "cocktail" approach is advisable, combining many BRMs to target each of these pathways and approach a synergistic cytostatic effect.
Dietary Strategies: Build a Solid Foundation
The dietary recommendations for brain tumor patients have 3 general goals: (1) increased intake of cancer-fighting phytonutrients, (2) modulation of tumor-promoting eicosanoids, and (3) regulation of blood sugar levels.
A Nutrient-Dense Diet: Increase Vegetable and Fruit Intake
A healing diet consists of organically raised foods in their whole, natural, unrefined, and unprocessed state. The client should avoid (or limit) processed, refined foods and avoid nitrates in preserved meats and fish, which are linked epidemiologically to brain tumors.
A diversity of plant foods rich in cancer-fighting phytonutrients should be emphasized. These include carotene-rich foods, cruciferous vegetables, chlorophyll-rich leafy greens, antioxidant-rich berries (eg, blueberries, cherries, and raspberries), soy products, flax seeds, and green "super" foods (eg, chlorella, spirulina, wheat grass). Liberal use of garlic, ginger, turmeric, rosemary, and thyme should be encouraged, provided they do not exacerbate the client's nausea. With a new focus in research on gene-nutrient interactions, it appears that phytonutrients are capable of suppressing oncogene expression and upregulating tumor suppressor genes. Armed with the knowledge that these foods may directly "talk to the genes," the client may be encouraged to gradually increase intake of whole fruits and vegetables to 8 to 12 half-cup servings daily.
Vegetables should make up the bulk of the diet. The proposed diet offers 10% to 20% fewer calories than the standard American diet the client has previously been eating while at the same time increasing nutrient intake. Moderate dietary restriction of this type has been demonstrated in animal studies of astrocytoma to inhibit tumor growth by nearly 80% and to reduce tumor microvessel density (a marker of angiogenesis) by 200%, while increasing tumor apoptotic index 3-fold. 4 Increased volume of low-calorie plant-based foods can assist in controlling appetite elevated by decadron, while helping to prevent weight gain commonly occurring in brain tumor patients taking this medication.
Dietary Strategies for Modulating Prostaglandins
Compared to healthy brain tissue, brain tumor cells have increased concentrations of arachidonic acid and significantly lower levels of omega-3 fatty acids. 5, 6 Consequently, production of inflammator y prostaglandins is significantly increased in brain tumor tissue. 5, 7 Inflammatory eicosanoids (eg, PGE2 and LTB4) promote tumor growth and invasion while suppressing local immune function. 8 Dietary strategies can help reduce the availability of lipid substrates for proinflammatory eicosanoids. Intake of saturated fats (arachidonic acid found in meat, dairy, and poultry) should be restricted, and careful avoidance of hydrogenated and trans-fatty acids is recommended. These fats are precursors of tumor-promoting and immune-suppressing series 2 prostaglandins and series-5 leukotrienes. While a vegetarian (or mostly vegetarian) diet can be useful in accomplishing this goal, this client's history of hypoglycemic-type symptoms (low energy and napping in the afternoons, cravings for sweets and chocolate) and (fasting?) blood glucose level of 107 suggest the need to incorporate some animal proteins into her diet. Acceptable would be organically raised nonfat dairy products (preferably cultured with living probiotic bacteria), skinless white meat poultry, and occasional lean meats with all visible fat trimmed and cooked such that the fat drips away from the meat. The highest quality, free-range, hormone-and antibioticfree meats and poultry should be selected.
Plant sources of omega-6 fats (abundant in nearly all vegetable oils except olive oil and flaxseed oil) should also be limited. Despite their potential to form the favorable prostaglandin E1 (PGE1), omega-6 lipids are shunted toward arachidonic acid in the presence of elevated blood sugar and insulin, as occurs in brain tumor patients taking corticosteroids. Therefore, I do not advise inclusion of gamma linolenic acid (GLA), as found in evening primrose oil or borage oil, for oral intake. (Note that 2 studies of topical application of GLA intratumorally during surgery have reported a favorable antitumor response, although the mechanism of action here is likely prooxidative. With oral consumption, the body's antioxidant resources limit this oxidative effect, and the GLA will likely be metabolized toward inflammatory mediators known to promote tumor growth.)
Omega-3 fatty acids-precursors of tumor-fighting and immune-boosting series 3 eicosanoids-found in cold-water fish and flaxseed oil should be emphasized. Fish less likely to contain harmful amounts of mercury (such as sardines and salmon) may be emphasized over other cold-water fish choices. A purified fish oil supplement can also help achieve optimal omega-3 intake without risk of toxicity (look for products that are independently tested and free of rancidity, mercury, polychlorinated biphenyls, dioxin, and bacterial contamination).
Aim for a therapeutic 1:1 ratio of omega-6 to omega-3 fats. Olive oil (omega-9) may be used for lowheat sautéing, baking, and for table use (eg, salad dressing).
The Importance of Healthy Blood Sugar Regulation
Several studies support the connection between blood glucose levels and glioma tumor metabolism, demonstrating that brain tumors rely on glucose as their primary fuel and that elevated glucose levels increase tumor cell metabolism independent of changes in blood supply to the tumor. 9,10 An eye-opening study was recently published in the British Journal of Cancer by Thomas Seyfried and colleagues at Boston College. In this study, feeding more calorie-rich carbohydrates and sugars to mice promoted the growth of brain tumors and also promoted angiogenesis. 11 The researchers concluded that "since neural [brain] tumors utilize glucose almost exclusively as their main energy substrate, brain tumors may be more receptive to dietary and nutritional therapies than non-brain tumors."
Elevated blood sugar has additional deleterious effects for cancer patients. It suppresses immune function and increases insulin release, shifting the production of prostaglandins toward inflammatory eicosanoids that can promote tumor growth.
The client should be instructed to follow a hypoglycemic-type diet plan. Refined and processed carbohydrates with high glycemic index should be restricted; whole-grain, high-fiber complex carbohydrates low in glycemic index should be emphasized. Choose whole fresh or frozen fruit rather than fruit juices or dried fruits. Limit starchy vegetables.
Frequent, small meals are preferred. A balanced intake of macronutrients is recommended, providing 20% to 25% of calories from protein, 25% to 30% from fats (emphasizing essential fatty acids), and not more than 55% of total calories as carbohydrates. As meal composition can influence glycemic load, the client should be instructed to avoid eating carbohydrate foods alone but rather to eat them in combination with proteins and healthy fats. Adequate protein intake is essential, as protein needs increase following neurosurgery and during radiation and chemotherapy. Increased protein intake can also reduce cravings for sweets. Plant-based proteins are an ideal choice (being devoid of arachidonic acid, precursor of inflammatory eicosanoids); however, nonfat, low-fat dairy, and lean meat and poultry may be included as outlined above.
Ample fiber intake-at least 35 grams per day-fosters healthy blood sugar regulation while also promoting a healthy intestinal environment. It can reduce the constipation frequently accompanying chemotherapy treatment with temozolomide (Temodar).
Developing an Herbal and Dietary Supplement Protocol to Complement the Client's Medical Treatment
Dietary supplements should be selected from reputable professional quality suppliers, emphasizing those products with independent lab testing for purity and potency. New dietary supplements should be started one at a time with a 2-to 3-day observation period to ensure no side effects or reaction to the agent before adding the next agent. A qualified practitioner and/ or pharmacist should review the client's medications and proposed supplements to reduce the risk of potential drug-nutrient interactions. The client's neurooncologist should be advised regarding the diet and supplement protocol.
Anti-inflammatory Protocol
Tumors use inflammatory chemicals (such as PGE2, made from the action of the cyclooxygenase-2 [COX-2] enzyme on omega-6 fats) to fuel their growth, foster invasion, and also to promote the angiogenesis process (reviewed by Wallace 8 ). Inflammatory chemicals, such as COX-2 and PGE2, are greatly elevated in brain tumor tissue. 5, 12, 13 In one recent study, excessive amounts of inflammatory compounds was the strongest predictor of poor outcome for glioma patients. 14 Anti-inflammatory drugs can effectively inhibit the growth of brain tumor cells in vitro. 15 Taking steps to reduce inflammation should help reduce the headaches this client has been experiencing and may reduce her need for dexamethasone.
Selective COX-2 inhibitors-celecoxib and rofecoxib-are currently under investigation as adjunct therapies for brain tumor patients. But these drugs block only COX-2. A second pathway, lipoxygenase (LOX), creates inflammatory compounds called leukotrienes (such as LTB4) and hydroxyeicosate-traenoic acids (HETEs), which are perhaps more strongly implicated in brain tumor growth. Inhibitors of both COX-2 and LOX have been demonstrated to inhibit the growth of glioma cells; however, some studies have shown LOX inhibitors to be more potent in slowing brain tumor growth. 16 Agents that block the arachidonic acid cascade, such as COX and LOX inhibitors, have been demonstrated to inhibit the growth of glioma cells. 17, 18 Two botanical compounds helpful in this regard are bromelain and boswellia.
The selection of anti-inflammatory agents and their dosing can be individually tailored based on results of C-reactive protein (CRP) testing. The CRP test is an extremely sensitive measurement of inflammation. While this test is most well known for its role in assessing the risk of heart disease and stroke, numerous studies have demonstrated the prognostic value of the CRP test in cancer patients. [19] [20] [21] [22] Bromelain (Ananas comosus) Bromelain, an enzyme preparation derived from the woody stem of pineapple, blocks the production of PGE2, 23 an inflammatory prostaglandin that feeds tumor growth and invasion, increases pain, promotes angiogenesis, and suppresses immune function.
Bromelain has several actions that make it an ideal adjunct throughout the care of brain tumor patients. Concentrated bromelain preparations reduce inflammation by blocking PGE2, increase production of immune-boosting cytokines, exert a mild fibrinolytic activity and help prevent thrombosis (a common occurrence in brain tumor patients, particularly those with focal motor deficits that limit mobility), improve circulation, and provide antitumor effects (reviewed by Kelly 24 ). Bromelain's anti-inflammatory action has been demonstrated in human studies. 25 In working with more than 600 brain tumor clients over the past 6 years, the author has observed bromelain to offer superior effects on intracranial inflammation over other proteolytic preparations, such as pancreatin, at a dose of 500 to 750 mg bromelain (2400 gdu per gram potency), 3 times a day on an empty stomach.
During the 2001 meeting of the Society of Neurooncology, doctors from Norway presented an abstract showing that bromelain effectively reduces glioma cell migration and invasion into healthy tissue in vitro. 26 Further analysis shows bromelain significantly reduces glioma cell adhesion, migration, and invasion (without affecting cell viability), even months after treatment. 27
Boswellia (Boswellia serrata)
Boswellia is a selective inhibitor of the 5-LOX, 28 inhibiting the production of leukotrienes (such as LTB4), which are known to stimulate brain tumor growth and increase brain edema. 29 In one study, patients with malignant glioma were given high-dose boswellic acids prior to craniotomy for tumor recurrence and were prohibited corticosteroids. After 7 days, boswellia achieved a mean 30% reduction in peritumoral edema, with marked improvement in clinical symptoms. 30 This study reports the effective dose of boswellic acids to be in the range of 1800 to 3200 mg/d. Two additional human studies have confirmed the anti-inflammatory effects of boswellia in brain tumor patients. 31, 32 Boswellia supplements have also been shown to be safe and effective in treating brain edema associated with radiation therapy, chemotherapy, and/or leukoencephalopathy. 31 Additional preclinical research suggests boswellic acids are cytotoxic to brain tumor cells and can induce apoptosis in glioma cells in vitro and in vivo. [33] [34] [35] Taking this herb with meals reduces the risk of gastrointestinal discomfort, (occurring at a 1%-3% incidence rate).
Omega-3 Fatty Acids
High-quality fish oils provide omega-3 fatty acids, which are the substrate for the production of antiinflammatory PGE3 and help block the production of PGE2. Fish oil contains 2 important omega-3 fats: eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). DHA is an essential lipid in the structure of healthy brain cells and can assist brain repair following surgery, radiation, or chemotherapy treatments. EPA and DHA have been shown to inhibit tumor growth and invasion, whereas omega-6 fats have been shown to promote tumor growth and invasion. 36 In a randomized controlled clinical trial on patients with stage IV cancers metastasized to the brain, those who were supplemented with fish oils following completion of radiotherapy had 64% greater survival rates over a 2-year period than did patients receiving placebo. 37 The study employed a daily fish oil dose of 2000 mg EPA and 1000 mg DHA.
Nettles (Urtica dioica)
The anti-inflammatory action of Urtica dioica, or "stinging nettles," is of interest to brain tumor patients, even though no human studies have yet examined the effects of nettles in this population. When COX-2 is blocked, a chemical messenger called thromboxane A2 (TxA2) becomes elevated. Elevated TxA2 in turn causes levels of leukotriene B4 (LTB4) and tumor necrosis factor-α (TNF-α) to rise. 38, 39 LTB4 and TNF-α are potent inflammatory agents. In a human study, nettles extracts, taken orally for 3 weeks, suppressed TNF-α. 40 Nettles also blocks the LOX-5 pathway of inflammation, particularly inhibiting the production of LTB4. 41, 42 An animal study by Dr Michelle Monje at Stanford University published in the December 5, 2003, issue of Science 43 has shown that after radiation, 2 key producers of inflammatory response in the braininterleukin 6 (IL-6) and TNF-α-appear to be major culprits in the brain's ability to recover from damage, affecting cognitive performance, learning, and memory. Dr Monje's finding suggests it is inflammation that inhibits neurogenesis. This finding suggests that agents that block IL-6 and TNF-α can help heal the brain after injury or radiation therapy, a finding that would clinically benefit this client who is experiencing difficulties with memory, organization, word finding, and other cognitive skills.
TNF-α can be blocked by nettles. Suggested dose would be 500 to 850 mg, twice a day between meals, 40 to 60 g of cooked fresh herb, or 3 to 4 cups of nettles tea per day.
Curcumin, quercetin, ginger, and other antiinflammatory herbs could be added as needed, although these herbs are less well researched for this purpose.
Angiogenesis Inhibition and Copper Depletion
Many angiogenesis-promoting enzymes-such as vascular endothelial growth factor, basic fibroblast growth factor, TNF-α, and IL-1-are copper dependent. 44 Copper is a required cofactor for the function of these key mediators of angiogenesis. Without copper, the function of these enzymes is suppressed and angiogenesis is impeded.
Patients with brain tumors frequently have elevated copper levels, and their serum copper and ceruloplasmin (a protein that contains 95% of the copper found in human plasma) values tend to rise with increasing disease activity. 45 Elevated copper levels in brain tumor patients have been shown to return to normal following successful treatment. 46 In 1990, Dr Stephen Brem (from the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida) published studies showing that copper fosters brain tumor angiogenesis in vivo. 47, 48 Dr Brem's experiments demonstrate that the depletion of copper is an effective antiangiogenesis strategy, halting the growth of brain tumors in animals. Other researchers have confirmed the relationship between copper and angiogenesis in brain tumors, also demonstrating that copper depletion can effectively slow or halt glioma tumor growth in animals. 49, 50 Two human clinical trials have been conducted on copper reduction protocols. Drs George Brewer and Sophia Merajver, from the University of Michigan, published the results of a phase I trial of copper reduction using the drug tetrathiomolybdate (TM) in patients with various advanced stage IV cancers. The drug took about 8 to 10 weeks to substantially reduce copper levels, and some patients' cancers progressed before copper levels dropped low enough. All patients in the trial who successfully lowered their copper levels achieved stable disease over a 1-year period. 44 A recently conducted phase I/II trial on brain tumor patients and copper reduction using the drug Dpenicillamine was sponsored by New Approaches for Brain Tumor Treatment and Johns Hopkins Hospital in Baltimore. The results are awaiting publication. In an interview published in the Journal of the National Cancer Institute, lead researcher Dr Brem said of the study, "So far, the approach is effective in lowering serum copper, compliance with the diet and medication is good, and no severe toxicities have occurred. A few patients have experienced disease stabilization and one has had a complete response. 51 Strategies to reduce copper levels are clearly warranted in a nutritional protocol for brain tumor clients. Foremost, intake of copper may be reduced by the following steps: While clinical trials employing copper reduction as the primary anticancer therapy have attempted to reduce copper levels to about 20% of a patient's baseline measurement, I feel this may be too low (and could cause copper-deficiency symptoms, such as anemia, osteoporosis, immune suppression, and poor collagen integrity resulting in ruptured blood vessels). When combining copper chelation with protocols to address inflammation, increase apoptosis, promote differentiation, and target tumor progression through multiple pathways, it is possible that less drastic reduction in copper levels will still provide some benefit. Because copper is necessary for the absorption and use of iron, excessive copper reduction creates iron-deficiency anemia. Monitoring of hemoglobin, mean corpuscular volume, mean corpuscular hemoglobin, and mean corpuscular hemoglobin concentration levels can ensure the safety of this copper-reduction strategy. With physician supervision and monitoring, copper may be depleted to a level that does not reduce hemoglobin level below 11 g/dL for men or 9 g/dL for women.
Certain nutritional supplements can reduce intestinal uptake of copper or promote copper chelation and excretion. Molybdenum competes with copper for absorption and is used successfully in the author's clinic for significant reduction of copper levels (TM, prepared by a compounding pharmacy, was employed in the above phase I clinical trial as a copper-chelating agent). Vitamin C at moderately high doses (1500-3000 mg/d in divided doses) helps reduce copper levels. Zinc, as zinc sulfate or glycinate, competes with copper for absorption (and is typically used to assist control of copper levels in Wilson's disease). Zinc supplementation induces metallothionein, a protein carrier known to bind copper and promote its excretion. Alpha lipoic acid is a thiol-containing substance that chelates copper, although its compatibility with chemotherapy treatment has not been explored. Chlorella (Chlorella pyrenoidosa) increases albumin levels and reduces copper levels. In a study done by Dr Randall Merchant at the Medical College of Virginia, 7 out of 20 patients with various high-grade brain tumors survived beyond 2 years while taking chlorella as part of their treatment protocol. 52 In some cases, copper level fails to decrease as expected, and underlying contributors should be explored. States of inflammation can drive copper levels up. Some medications can elevate copper levels, such as tamoxifen, oral contraceptives and hormonereplacement therapy, and certain antiseizure medications. Estrogen dominance can produce elevated copper levels. Underlying cardiovascular disease-or vascular damage resulting from chemotherapy-may be an underlying factor for elevated copper that is difficult to lower.
Copper chelation protocols should be discontinued in pregnancy, for surgery (as angiogenesis is necessary for proper wound healing), and in cases of advanced cardiovascular disease.
Impede Invasion
While glioblastoma very rarely metastasizes outside the brain, it is a highly invasive tumor. No human studies have explored the use of nutritional or herbal agents to inhibit the invasive properties of gliomas. However, preclinical studies suggest some agents may be useful for this purpose.
Alkylglycerols
Alkylglycerols are ether lipids abundant in purified shark liver oil. Researchers have found the alkyl-lipids have a direct effect on glioma cells, reducing glioma growth by up to 50% and inhibiting the invasion of glioma cells into healthy brain tissue. 53 In this study, biopsy samples of glioblastoma multiforme and anaplastic astrocytoma were cultured with healthy brain tissue and treated with alkylglycerols. The results showed a 7-fold preservation of normal brain tissues compared to controls not treated with alkylglycerols.
Alkylglycerols are mildly immune boosting and can help elevate a low platelet count, which may be particularly useful for this client (current platelet at 161 µ/ L) with continued chemotherapy. Care should be taken to select a product that is carefully purified of heavy metals, toxicants, and excess amounts of vitamin A and D. A dose of 500 mg purified shark liver oil 3 times a day with meals is recommended; the dose may be doubled if the platelet count falls below normal.
Green Tea Catechins
Green tea catechins may also help hinder glioma invasion. Epigallocatechin-gallate (EGCG) potently inhibits matrix metalloproteinase enzymes that foster invasion of brain tumor cells into healthy brain tissue. 54 EGCG inhibits protein kinase in brain tumor research (protein kinase is an enzyme needed by tumor cells to promote their proliferation). 55, 56 Other studies report that within 72 hours of exposure to green tea, glioma brain tumor cells had greatly reduced viability and undergo apoptosis. 57, 58 Clinical trials to test the effects of green tea in humans with brain tumors have not yet been conducted, but as it is a healthful and tasty beverage, the client may be encouraged to drink green tea, 3 or more 6-to 8-oz cups daily. A green tea supplement may also prove useful, 300 mg standardized to 60% to 90% polyphenols and 40% to 55% epigallocatechin, 3 times a day.
Apoptosis
Preclinical research continues to report proapoptotic effects of many nutrients and herbs in vitro and in vivo. Several nutrients, many discussed herein, appear to induce apoptosis in glioma, particularly green tea, boswellic acids, ginsenoside Rh-2 from Panax ginseng, soy genistein, selenium, and zinc. Vitamin E succinate and vitamins A, C, D, and K have been shown to help regulate apoptosis.
Berberine
Berberine is a plant alkaloid found in herbs such as goldenseal, barberry, and Oregon grape root. In vitro studies have reported that berberine is effective in inducing apoptosis in glioma cells. [59] [60] [61] In a compelling animal study, rabbits with glioma tumors were stratified into 3 groups: (1) BCNU chemotherapy alone, (2) berberine alone, and (3) a combination of BCNU plus berberine. After 7 days of treatment, tumors were removed and examined. BCNU achieved a 30% kill rate over the 7 days of treatment.
Interestingly, berberine alone had an equal cytotoxic effect. When the two were combined (BCNU + berberine), the tumor kill rate jumped to more than 90%, showing a potent synergistic effect. 62 The dose of berberine used in this study was fairly low: 10 mg/kg bodyweight (about 600-800 mg/d as scaled to human use). Berberine alkaloids are very healing and protective to the liver, boost immune function, and also help maintain normal balance of bacteria in the intestinal tract.
Differentiation
Vitamins A and D Numerous research studies have demonstrated the ability of vitamins A and D to redifferentiate various types of cancer cells, causing the cells to behave like normal cells and take on a more healthy phenotype. Vitamin A analogues (eg, Accutane) are often helpful adjunctive therapy in treating glial tumors, and other research has suggested that vitamins A and D may work together in this regard.
Preclinical studies on vitamin D and brain tumors have shown that the vitamin exerts a cytotoxic effect against glioma cells in culture 63, 64 and induces both differentiation and apoptosis (programmed cell death) in glioma cell lines. 65 In a recently published phase II study, 27% of patients with malignant glioma experienced a significant response to a synthetic vitamin D drug, alfacalcidol. 66 In this small but impressive study, 3 of 11 patients (2/10 with glioblastoma multiforme IV, and 1/1 with astrocytoma III)-whose tumors were unresponsive to prior radiation and chemotherapyresponded to the vitamin D treatment with tumor stabilization or progressive tumor regression as demonstrated on their magnetic resonance images. These patients experienced significant improvements in their clinical symptoms, and there were no side effects from the treatment. Responding patients showed complete clinical remission for 4, 5, and 7 years (with a median survival time of the treated group of 21 months). While the study is small, the outcome is remarkable, particularly in lieu of the safety of the treatment. The dose used was 0.04 mcg/kg of alfacalcidol.
Vitamin D analogues or natural vitamin D3 supplements may have an added benefit of helping reduce the risk of bone loss associated with prolonged use of decadron by brain tumor patients.
Immune Enhancement
Brain tumor patients have been shown to have serious immunosuppression, including profound suppression of their natural killer (NK) cell activity. 67 Numerous botanical agents may be considered for their immuneboosting effects such as astragalus, Panax ginseng, ashwagandha, echinacea, garlic, and mushrooms extract (particularly maitake D-fraction, Coriolus versicolor, reishi, and shiitake). Antioxidants, vitamins A, C, E; carotenoids; selenium; and zinc stimulate immune function. Vitamin C significantly enhances NK cell activity. One clinical study demonstrated a 10-fold increase in NK cell activity in patients following administration of vitamin C in oral doses of 60 mg/kg bodyweight. 68 Stress reduction, adequate sleep, and visualization techniques can also be powerful stimulators of immune response.
Melatonin
Early research demonstrated that melatonin had direct inhibitory effects on brain tumor cell growth, 69 particularly when supplemented at the onset of the dark phase. In a particularly compelling clinical trial, glioblastoma multiforme patients were given oral melatonin (20 mg at bedtime) for 1 year, commencing at the start of radiation therapy. Melatonin-supplemented patients had increased survival at 1 year compared to those not taking the supplement (43% vs 6% surviving). 70 Melatonin also reduced radiation side effects and decadron-related toxicity in this study and offered immune-boosting, anti-inflammatory, and antiproliferative effects.
Other research by Dr Paolo Lissoni on human brain tumor patients found that melatonin can greatly improve the efficacy of immunotherapies for brain tumors 71 and may have direct anti-inflammatory properties. 72 Melatonin supplements can rescue the bone marrow function following chemotherapy and reduce other chemotherapy-related side effects [73] [74] [75] while improving tumor response and lengthening survival duration in stage IV cancer patients. 73, 76 Some research has also shown that melatonin therapy can reduce the frequency of seizures in epileptic patients. 77
Selenium
Selenium is essential for optimum function of the immune system. It increases IL-2, which stimulates the production of white blood cells. In one study, supplementation with 200 mcg/d selenium increased the ability of lymphocytes to kill tumor cells by 118% and increased the activity of NK cells by 82%. 78 Several research studies have demonstrated that the trace mineral selenium may offer potential benefits for brain tumor patients. Animals with implanted glioma tumors supplemented with low doses of selenium (0.5-2.0 mcg/g) significantly outlived animals fed selenium-deficient diets. 79 Selenium supplementation was associated with improved symptoms and prolonged survival in 20% of patients with glioblastoma multiforme brain tumors. 80 As this was a small study (15 patients) , the authors called for additional research. In a clinical trial, 32 brain tumor patients who had previously received surgery, radiation, and chemotherapy were given 1000 mcg/d selenium. All of the patients showed some benefit, with significant improvements-reduced levels of headaches, seizures, nausea/vomiting, and unsteady gaitobserved in 76% of the patients. 81
Comments on Steroidal Antiinflammatory Medication (Dexamethasone)
Dexamethasone, while essential for the control of intracranial pressure and peritumoral edema, is associated with considerable systemic side effects and potentially life-threatening complications, particularly with long-term use. These include increased appetite, weight gain, hyperglycemia, hyperlipidemia, gastrointestinal bleeding and perforation, peripheral edema, osteopenia, immune suppression (with increased risk of opportunistic infections), adrenal insufficiency, hypothalamic-pituitary-adrenal axis disruption, muscle atrophy, insomnia, fragile skin, and inhibition of wound healing. Several dietary and nutritional interventions can be used to manage these, summarized briefly below and reviewed in more detail elsewhere. 82 Care should be taken to restrict the use of this medication only for as long as medically necessary. Use of nutritional and botanical anti-inflammatory strategies (outlined below) can help reduce dependence on steroidal anti-inflammatory agents in this patient. When prolonged use of decadron is necessary, a physiologic dosing schedule that follows the natural circadian rhythm of cortisol secretion (highest dose in the morning with smaller dose(s) at noon or afternoon and no medication taken in the evening) can reduce side effects associated with the drug and lessen the risk of decadron dependence. For patients taking decadron for prolonged time periods, considerable care should be taken with a gradual tapering schedule. Watch for rebound inflammation (increase doses of nutritional/botanical anti-inflammatory agents during tapering) and adrenal stress, which may require support.
Dietary modifications following a hypoglycemictype diet (avoidance of refined and processed carbohydrates, emphasis on complex high-fiber carbohydrate intake balanced with protein, smaller more frequent meals) can help reduce weight gain and provide for healthy blood sugar regulation. This patient's symptoms of daytime (afternoon) napping and cravings for sweets suggests possible blood sugar dysregulation. Detailed educational support, goal setting, and coaching (combined with her husband's support) will be helpful in successful dietary modification.
Decadron depletes several nutrients: vitamins B6, B12, C, D; folic acid; calcium; potassium; zinc; and selenium. A multiple vitamin/mineral (without copper) can help replenish these. Long-term use also appears to decrease levels of melatonin and DHEA.
Gastric protection may be prudent. Histamine H2 antagonists or antacids are frequently prescribed prophylactically with decadron to reduce the risk of gastrointestinal bleeding. Blocking gastric acid, however, interferes with protein digestion and removes gastric acid needed for absorption of calcium and other nutrients. In addition, gastric acid serves to protect against bacterial and yeast infections. It may be preferable to employ botanical strategies for gastric protection. Deglycyrrhizinated licorice, slippery elm, or other mucilaginous herbs may be useful in decreasing the risk of gastrointestinal bleeding. Alcohol consumption should be limited as it may increase gastric irritation.
Weight-bearing exercise and progressive strength training is useful in limiting bone loss, together with adequate intake of calcium and vitamin D. In addition, exercise improves blood sugar regulation, lowers insulin levels, reduces muscle wasting associated with decadron, improves mood, and promotes a positive sense of well-being.
Patients should be counseled on potential drug interactions associated with dexamethasone. Avoid St. John's wort (Hypericum perforatum) and ephedra (Ephedra sinica), both inducers of cytochrome P450 (3A4), which may speed clearance of the drug and reduce its efficacy. Grapefruit may inhibit clearance and increase associated side effects and toxicity. Caution and supervision should be employed when using digitalis glycosides and diuretic or laxative-acting herbs for their possible risk of increasing electrolyte imbalances associated with decadron use.
Licorice (Glycyrrhiza glabra), due to its glycyrrhizin content, may have antagonistic or agonistic effects combined with corticosteroids. Licorice extracts increase the half-life of circulating corticosteroids, prolonging their action and possibly potentiating their anti-inflammatory effects. The actions of the herb may help counteract steroid-induced hyperlipidemia, adrenal atrophy, thymic atrophy, and immunosuppression. However, at high doses (> 10 g/d) for prolonged periods, licorice can increase both potassium wasting and hypernatremia, increasing the risk of peripheral edema and hypertension. 82
Comment on Antiseizure Medication (Phenytoin)
This patient is being managed prophylactically on antiseizure medication. Phenytoin depletes vitamins B6, B12, and K; folic acid; biotin; calcium; and magnesium. The drug interferes with the activity of vitamin D and depletes blood levels of melatonin. Several of these nutrient depletions are shared with decadron, highlighting the importance of daily supplementation with a multiple vitamin/mineral (without copper). While dilantin can deplete folic acid and vitamin B6, high doses-folic acid greater than 2000 mcg/d or vitamin B6 greater than 80 mg/d-can interfere with the antiseizure actions of the drug, leading to breakthrough seizures.
Particular care should be taken with agents that speed hepatic clearance-for example, St. John's wort (Hypericum perforatum) and milk thistle (Silybum marianum)-as these may decrease blood levels of phenytoin below therapeutic range (10-20 µg/mL). Conversely, agents that inhibit liver clearance or excess dietary fats may increase dilantin blood level above 20 µg/mL and increase toxicity.
Dietary strategies to help regulate blood sugar levels can enhance control of seizures. Avoid neuro-toxins, coined "excitotoxins" by Russell Blaylock, MD, such as monosodium glutamate, aspartame, and NutraSweet.
Magnesium deficiency and/or excess calcium intake may lower seizure threshold. Vitamin E appears to enhance the efficacy of antiseizure medications.
The amino acid taurine also appears to play a role in seizures. 83 Both human and animals studies have shown that radiation and chemotherapy treatments deplete taurine levels and that the severity of taurine loss is directly associated with the severity of side effects from the treatment. 84, 85 Taurine deficiency may have a role in myelosuppression (bone marrow suppression) following these therapies, particularly as taurine is the most abundant amino acid in white blood cells and platelets. When animals undergoing radiotherapy are supplemented with taurine, they have fewer side effects and their white blood cell counts recover more rapidly. 83, 86 If the patient develops seizure (not uncommon in frontotemporal lobe tumors), supplementation with taurine, magnesium, zinc, and vitamin E may decrease seizure frequency or severity and complement antiseizure medication in controlling seizures.
Summary Lab Recommendations
Laboratory assessments can be taken at baseline to identify biochemical pathways most in need of being addressed for this patient so that her nutritional protocol can be tailored to her individual needs. Follow-up testing can be used to monitor the efficacy of nutritional intervention and allow fine-tuning of protocol.
• High sensitivity CRP to monitor anti-inflammatory protocol • Serum copper and ceruloplasmin to monitor antiangiogenesis protocol • Serum calcium and phosphorous to monitor safety of redifferentiation therapy with vitamin D • Oxidative stress and antioxidant nutrient status to monitor dietary modifications (possible need for additional vitamin E and antioxidant intake associated with increased omega-3 intake) • Fasting glucose, triglyceride, and insulin to monitor compliance with dietary modifications to regulate blood sugar levels • Functional adrenal assessment (with 24-hour cortisol circadian pattern) to monitor adrenal competence at completion of steroid therapy • Hepatic detoxification profile to explore possible alterations in phase I (cytochrome 450) and phase II (conjugation) detoxification pathways, which may contribute to nausea and sensitivity to scents and may significantly alter chemotherapy efficacy
